CASTLE MEDICAL GROUP PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: E81013 | LUTON, LU1 3AG
Showing results 401-450 of 618
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sodium fluoride | 35 | 6,160 | £247 | +5.5% ▲ |
| Fluorometholone | 35 | 240 | £74 | +143.0% ▲ |
| Omega-3-acid ethyl esters | 34 | 3,808 | £1.8K | +60.9% ▲ |
| Vortioxetine | 34 | 448 | £424 | -51.0% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 34 | 1,020 | £2.4K | +37.1% ▲ |
| Travoprost | 34 | 158 | £116 | -27.8% ▼ |
| Dorzolamide | 34 | 2,050 | £838 | -59.1% ▼ |
| Permethrin | 34 | 2,160 | £645 | -9.8% ▼ |
| Glycopyrronium bromide | 34 | 278 | £497 | +42.7% ▲ |
| 34 | 34 | £176 | -33.7% ▼ | |
| Ursodeoxycholic acid | 33 | 5,204 | £971 | -50.1% ▼ |
| Terbutaline sulphate | 33 | 42 | £332 | -39.2% ▼ |
| Domperidone | 33 | 2,446 | £141 | -7.5% ▼ |
| Azelaic acid | 33 | 990 | £161 | +38.0% ▲ |
| Co-tenidone (Atenolol/chlortalidone) | 32 | 1,764 | £245 | +53.4% ▲ |
| Pimecrolimus | 32 | 1,740 | £1.0K | +89.0% ▲ |
| Naloxegol | 31 | 1,050 | £1.8K | +124.8% ▲ |
| Clonidine hydrochloride | 31 | 2,042 | £159 | +69.7% ▲ |
| Rimegepant | 31 | 188 | £2.4K | +216.0% ▲ |
| Zonisamide | 31 | 6,643 | £3.5K | -28.9% ▼ |
| 31 | 4,620 | £7.4K | +46.4% ▲ | |
| 31 | 2,028 | £161 | -85.7% ▼ | |
| Fluticasone furoate/vilanterol | 30 | 43 | £1.2K | -80.6% ▼ |
| Trihexyphenidyl hydrochloride | 30 | 4,926 | £1.7K | +5.8% ▲ |
| Quinine bisulfate | 30 | 1,204 | £217 | -22.7% ▼ |
| Propylthiouracil | 30 | 2,632 | £956 | +138.7% ▲ |
| Other compound vitamin/mineral formulation preparations | 30 | 1,530 | £156 | -6.4% ▼ |
| Liquid paraffin | 30 | 19.5K | £230 | +332.4% ▲ |
| Umeclidinium bromide | 29 | 39 | £1.0K | -53.0% ▼ |
| Erythromycin | 29 | 2,026 | £788 | -16.3% ▼ |
| Ketoprofen | 29 | 2,400 | £104 | -19.2% ▼ |
| Brinzolamide/brimonidine | 29 | 245 | £430 | -15.5% ▼ |
| Acetazolamide | 29 | 5,096 | £196 | +33.8% ▲ |
| Clindamycin phosphate | 29 | 1,050 | £225 | +76.3% ▲ |
| 29 | 53 | £491 | +143.6% ▲ | |
| 29 | 189 | £344 | +75.7% ▲ | |
| Hyoscine hydrobromide | 28 | 1,692 | £267 | -18.0% ▼ |
| Levodopa/carbidopa/entacapone | 28 | 5,164 | £2.2K | +0.1% vs avg |
| Denosumab | 28 | 28 | £5.3K | +2.9% ▲ |
| Trospium chloride | 28 | 1,136 | £533 | -45.2% ▼ |
| Potassium chloride | 28 | 5,050 | £221 | +49.8% ▲ |
| Magnesium glycerophosphate | 27 | 5,544 | £2.3K | +96.5% ▲ |
| 27 | 612 | £2.3K | +62.3% ▲ | |
| Olmesartan medoxomil | 26 | 1,204 | £43 | -62.3% ▼ |
| Rasagiline mesilate | 26 | 1,260 | £909 | -30.0% ▼ |
| Medroxyprogesterone acetate | 26 | 1,590 | £258 | -32.1% ▼ |
| Meloxicam | 26 | 1,620 | £39 | -60.7% ▼ |
| 26 | 297 | £2.5K | +23.0% ▲ | |
| 26 | 500 | £237 | +24.8% ▲ | |
| Benzalkonium chloride | 25 | 6,250 | £140 | +118.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.